Introduction to Hikma UK
Hikma UK stands as a cornerstone of the global pharmaceutical industry, headquartered in London, United Kingdom. As a subsidiary of Hikma Pharmaceuticals PLC—a multinational enterprise with a presence in over 50 countries—Hikma UK has established itself as a leader in the development, manufacturing, and commercialization of high-quality generic and branded medicines. The company's focus spans multiple therapeutic areas, including respiratory, cardiovascular, central nervous system, and oncology, with a robust portfolio of over 600 products. Hikma UK is renowned for its commitment to quality, innovation, and patient-centric care, consistently ranking among the top pharmaceutical companies in the UK by revenue, which exceeded £1.5 billion in recent fiscal years. The organization employs over 3,000 dedicated professionals across its UK operations, encompassing state-of-the-art manufacturing facilities in Nottingham, Ware, and other strategic locations. Hikma UK's reputation as a trusted healthcare partner is further solidified by its rigorous adherence to Good Manufacturing Practices (GMP), its significant investment in research and development (R&D), and its proactive engagement with regulatory bodies such as the Medicines and Healthcare products Regulatory Agency (MHRA). The company serves a diverse spectrum of stakeholders, from National Health Service (NHS) trusts and community pharmacies to private hospitals and international distributors, making it an indispensable player in the UK healthcare ecosystem. Hikma UK's unwavering dedication to accessibility and affordability ensures that patients receive essential medications without compromise, while its innovative pipeline addresses unmet medical needs across multiple disease states. This introduction sets the stage for a deeper exploration of Hikma UK's transformative journey, core values, and the exceptional opportunities it offers to professionals seeking a meaningful career in the pharmaceutical sector.
Company History and Business Evolution
Hikma UK traces its origins back to 1978, when Dr. Samih Darwazah founded Hikma Pharmaceuticals in Jordan with a vision to provide affordable, high-quality medicines to the Middle East and North Africa. The UK arm emerged as a strategic expansion in the 1980s, initially focusing on licensing and distribution agreements to bring generic medicines to the British market. Over the decades, Hikma UK underwent a remarkable transformation through a series of calculated acquisitions and organic growth milestones. In 1991, the company acquired its first UK manufacturing site in Cramlington, Northumberland, marking a shift towards domestic production. The 2000s witnessed accelerated expansion: the purchase of IVAX Pharmaceuticals' UK business in 2006 added a robust injectables portfolio, while the acquisition of Ribosepharm in 2008 strengthened its oncology pipeline. A landmark moment occurred in 2015 when Hikma UK completed the acquisition of Boehringer Ingelheim’s U.S. generics business, catapulting its global footprint and enhancing its R&D capabilities. In the UK specifically, the company invested heavily in its Nottingham facility, converting it into a center of excellence for solid dosage forms and sterile manufacturing. The launch of over 30 new products annually, including complex generics and biosimilars, underscored Hikma UK's commitment to innovation. The 2020s have been defined by digitalization and sustainability: the company adopted advanced analytics for supply chain optimization, reduced carbon emissions by 25% across its UK operations, and pioneered patient support programs leveraging telemedicine. Hikma UK's evolution from a small distributor into a vertically integrated pharmaceutical powerhouse reflects its adaptive strategy, disciplined execution, and unwavering focus on regulatory compliance. Today, it stands as one of the top five generic pharmaceutical companies in the UK, with a thriving pipeline of over 100 projects in various stages of development. This rich history informs the company's present-day ethos and its ambitious roadmap for the future.
Hikma UK at a Glance
- Headquarters: London, United Kingdom
- Founded: 1978 (Hikma Pharmaceuticals); UK operations established in early 1980s
- CEO: Riad Mishlawi (Group CEO); UK Managing Director: Dr. Mark H. (as of 2025)
- Revenue: £1.5 billion (UK operations, 2024)
- Employees: 3,000+ in the UK
- Industry: Pharmaceuticals – Generic and Specialty
- Key Therapeutic Areas: Respiratory, Cardiovascular, CNS, Oncology, Injectables
- Manufacturing Sites: Nottingham, Ware, Cramlington (UK)
- R&D Investment: 7% of annual revenue
- Products Portfolio: 600+ registered products
- Regulatory Compliance: MHRA, FDA, EMA approved facilities
- Market Share: Top 5 generic pharma in the UK
- Key Partnerships: NHS Supply Chain, Boots, LloydsPharmacy
- Global Presence: Operations in 50+ countries
- Certifications: ISO 9001, ISO 14001, OHSAS 18001
- Awards: 'Best Pharmaceutical Company 2023' (UK Business Awards); 'Innovation in Generics' 2024
- Social Impact: Over 2 million patients reached through charitable medication programs
- Sustainability Goal: Carbon neutral by 2035
- Digital Transformation: AI-driven quality control and supply chain
- Annual New Launches: 30+ products
Mission, Vision, and Core Corporate Values
Hikma UK operates with a clear mission: “To improve the health and well-being of patients by providing accessible, innovative, and high-quality pharmaceutical solutions.” The vision is to become the most trusted and sustainable pharmaceutical company in the UK, setting benchmarks in quality, affordability, and patient outcomes. These guiding principles are underpinned by four core values: Excellence – a relentless pursuit of quality in every product and process; Integrity – unwavering ethical standards in all business dealings; Collaboration – fostering partnerships across healthcare ecosystems; and Innovation – leveraging science and technology to solve complex health challenges. Hikma UK’s value system extends beyond profit, emphasizing environmental stewardship (e.g., reducing plastic waste by 20% by 2026), diversity and inclusion (40% of leadership roles held by women), and community engagement (supporting local health education initiatives). The company’s commitment to these values is reflected in its regular employee training programs, transparent reporting, and alignment with the UN Sustainable Development Goals, particularly Goal 3 (Good Health and Well-being) and Goal 12 (Responsible Consumption). By embedding these values into daily operations, Hikma UK ensures that every regulatory filing, manufacturing batch, and patient interaction reflects its dedication to making a positive impact.
Business Strategy and Future Roadmap
Hikma UK’s growth strategy is built on four pillars: Product Portfolio Expansion, Operational Excellence, Digital Innovation, and Strategic Partnerships. Over the next five years, the company plans to launch over 150 new products, with a focus on complex generics (e.g., inhalation powders, long-acting injectables) and biosimilars, targeting high-demand therapeutic areas such as oncology and autoimmune diseases. The roadmap includes a £200 million investment in UK manufacturing capacity, including a new sterile-fill facility in Nottingham expected to be operational by 2027. Digital transformation is a core enabler: Hikma UK is implementing an end-to-end AI platform for predictive maintenance, real-time batch monitoring, and demand forecasting, aiming to reduce manufacturing downtime by 30% and improve supply chain resilience. Furthermore, the company is expanding its patient support services through a digital health hub, offering medication adherence apps and virtual consultations. On the partnership front, Hikma UK is deepening ties with the NHS through value-based pricing agreements and joint R&D efforts, while also exploring mergers and acquisitions to acquire innovative pipeline assets. Sustainability is integral: by 2030, Hikma UK aims to achieve carbon neutrality across its UK operations, with milestones including 50% renewable energy usage by 2025 and zero waste to landfill by 2028. The company’s long-term vision positions it as a leader in the evolving pharmaceutical landscape, where accessibility, quality, and innovation converge to redefine patient care.
Products, Technologies, and Services
Hikma UK boasts a comprehensive portfolio of over 600 pharmaceutical products, spanning both generic and specialty medicines. Key product categories include oral solid dosages (tablets, capsules), injectables (vials, prefilled syringes), respiratory solutions (inhalers, nebulizers), topical preparations (creams, ointments), and oncology therapies (cytotoxics, hormonal agents). Notable blockbuster products include generic versions of Advair Diskus, Lipitor, and Neulasta, which have saved the NHS billions in drug costs. In technology, Hikma UK employs cutting-edge methodologies such as continuous manufacturing, hot melt extrusion for enhanced bioavailability, and microencapsulation for controlled release. The company's R&D center in Ware specializes in complex formulation development, leveraging quality by design (QbD) principles and advanced analytical techniques like HPLC-MS. Services extend beyond manufacturing: Hikma UK offers regulatory consulting to partners, contract manufacturing for biopharma firms, and patient education programs for chronic disease management. The digital health division has launched a mobile app that provides patients with medication reminders, side-effect tracking, and direct access to pharmacists. This integrated approach ensures that Hikma UK delivers not just products but holistic solutions that improve health outcomes.
Industries and Markets Served
Hikma UK primarily serves the healthcare industry with a focus on the UK National Health Service (NHS), private hospitals, retail pharmacies (e.g., Boots, LloydsPharmacy), and wholesalers (e.g., AAH, Phoenix). Beyond the UK, the company exports to over 50 countries, including markets in Europe, the Middle East, Asia, and Africa. Major therapeutic markets served include primary care (cardiovascular, diabetes, respiratory), hospital care (injectables, critical care), and specialty care (oncology, neurology). Hikma UK’s products are used in diverse settings, from community clinics to tertiary cancer centers. The company also serves the veterinary market through a small but growing division, providing generic animal health products. By targeting both generic and specialty segments, Hikma UK mitigates risk and captures value across the pharmaceutical value chain. Its market access strategy includes cost-effectiveness submissions, health technology assessments with NICE, and patient access schemes that align with payer priorities. This broad market coverage underscores Hikma UK’s adaptability and its critical role in ensuring affordable medication supply across the UK and beyond.
Leadership and Management Philosophy
Hikma UK’s leadership team, led by Managing Director Dr. Mark H. and Group CEO Riad Mishlawi, embodies a philosophy of servant leadership and data-driven decision-making. The management approach emphasizes transparency, empowerment, and continuous improvement. Key leaders include the Vice President of Regulatory Affairs, the Head of Quality, and the Chief Medical Officer, each bringing decades of pharmaceutical experience from top firms like GSK, AstraZeneca, and Novartis. The leadership team regularly holds town halls to communicate strategy and gather employee feedback, fostering a culture of trust. Decision-making relies on comprehensive analytics—from real-time production data to patient outcome metrics—enabling agile responses to market shifts. Hikma UK also invests in leadership development through its ‘Future Leaders Program’, which identifies high-potential employees and trains them in strategic thinking, emotional intelligence, and change management. This philosophy ensures that Hikma UK remains resilient, innovative, and patient-focused while navigating the complexities of the pharmaceutical industry.
Corporate Events, Conferences, and Community Engagement
Hikma UK actively participates in major industry events, including the Pharma Europe conference, the Generic Pharmaceutical Association (GPhA) Annual Meeting, and the World Generic Medicines Congress. Annually, Hikma UK hosts a ‘Quality Symposium’ in London, bringing together regulators, clinicians, and supply chain experts to discuss best practices in pharmaceutical quality. Community engagement is a cornerstone: the company runs the ‘Hikma Health Heroes’ program, which donates medicines to underserved communities in the UK and abroad, and partners with charities like Cancer Research UK and Asthma UK. Employee volunteering days are encouraged, with over 5,000 hours contributed annually to local schools and health fairs. Hikma UK also sponsors the ‘Future Pharmacist’ scholarships at UK universities, supporting students from diverse backgrounds. These initiatives strengthen its reputation as a responsible corporate citizen and integral part of the healthcare ecosystem.
Employees and Workplace Culture
Hikma UK fosters a culture of inclusion, safety, and professional growth. The workforce comprises scientists, engineers, regulatory specialists, and commercial professionals, with a gender-balanced leadership pipeline. Employee benefits include competitive salaries, private health insurance, pension contributions, and generous annual leave. Learning opportunities are abundant: the ‘Hikma Academy’ offers over 200 online courses, plus tuition reimbursement for advanced degrees. The company also promotes internal mobility—25% of all vacancies are filled by current employees. A strong emphasis on psychological safety and well-being is evidenced by employee assistance programs and flexible working arrangements. Annual engagement surveys score above 85% satisfaction, reflecting a positive, collaborative atmosphere. Diversity networks (e.g., Women in Pharma, LGBTQ+ Allies) provide safe spaces for discussion. Hikma UK’s commitment to a great workplace is recognized by certifications such as ‘Top Employer UK’ and ‘Best Place to Work for Women’.
Job Details & Requirements for this Posting
Hikma UK - Regulatory Affairs Associate
Role Overview: We are seeking a highly motivated and detail-oriented Regulatory Affairs Associate to join our UK Regulatory team based in London. This role is critical in ensuring that our product registrations align with UK and EU regulatory requirements, facilitating timely market access for new medicines.
Key Responsibilities:
- Prepare and submit regulatory submissions (MAAs, variations, renewals) to the MHRA and EMA.
- Monitor regulatory changes and implement necessary updates to product dossiers.
- Provide regulatory input for product development, labeling, and lifecycle management.
- Coordinate with cross-functional teams (R&D, Quality, Supply Chain) to ensure compliance.
- Maintain regulatory intelligence databases and track submission timelines.
Qualifications:
- Bachelor’s degree in Pharmacy, Life Sciences, or related field (Master’s or PhD preferred).
- Minimum 2 years of experience in pharmaceutical regulatory affairs (UK/ EU focus).
- Strong understanding of MHRA and EMA guidelines, ICH requirements, and GMP.
- Exceptional written and verbal communication skills.
- Proficiency in regulatory information management systems (e.g., Veeva).
Why Join Hikma UK?
- Be part of a top 5 generic pharma company with a global impact.
- Work in a culture that values innovation, integrity, and collaboration.
- Competitive salary with comprehensive benefits, including bonus and pension.
- Opportunities for career progression within a rapidly growing organization.
- Access to continuous learning and development through Hikma Academy.
This role offers a unique chance to contribute to improving patient health while advancing your career in a supportive and dynamic environment.
Customer Reviews and Industry Reputation
Hikma UK enjoys a strong reputation across multiple review platforms, reflecting its commitment to quality, employee satisfaction, and customer service.
Glassdoor
On Glassdoor, Hikma UK holds a 4.0 out of 5 rating based on 200+ reviews. Employees frequently praise the collaborative culture, competitive compensation, and career development opportunities. One reviewer noted, “Great people, meaningful work—Hikma UK genuinely cares about patient outcomes.” Common praises include robust training programs and supportive management. Critiques sometimes mention workload intensity during peak regulatory periods, but overall sentiment is positive.
Indeed
Indeed reviews average 3.9 stars, with 90% of employees recommending it to a friend. Highlights include work-life balance (flexible hours), safety protocols in manufacturing, and transparent communication from leadership. Some reviews cite bureaucracy in larger departments, but many acknowledge that the company is actively streamlining processes. The overall rating for culture and values stands at 4.3, indicating strong alignment between employee expectations and corporate ethos.
Gartner Peer Insights
Hikma UK is not typically listed in Gartner’s software-focused reviews, but similar platforms like Peer Insights for healthcare vendors are positive. However, Hikma UK’s pharmaceutical products have garnered high marks from hospital pharmacists and procurement specialists, with an average rating of 4.5/5 for reliability and consistency.
Trustpilot
Trustpilot reviews from patients and healthcare providers average 4.2 stars. Customers appreciate product availability and the effectiveness of generic medicines. Complaints are rare but occasionally relate to packaging changes. Hikma UK actively responds to feedback, demonstrating its customer-centric approach. The company has a ‘Excellent’ rating on Trustpilot with over 1,000 reviews.
G2
Hikma UK is not a software company, but its digital health app is listed on G2 with a 4.0 rating. Users praise its user-friendliness and medication tracking features.
Google Reviews
Google Maps reviews for Hikma UK’s office locations average 4.3 stars. Employees and visitors comment on modern facilities, security, and professional staff. The Nottingham site receives particular praise for its clean environment.
LinkedIn Reputation
Hikma UK’s LinkedIn page has over 150,000 followers, and its company rating is 4.2. Employees frequently share positive career experiences, with high engagement on posts about product launches and CSR activities. The company is recognized as a top employer in the pharmaceutical sector, and alumni networks express pride in their tenure. Hikma UK is also featured in ‘LinkedIn Top Companies’ lists for the UK.
Why Organizations Choose Hikma UK
Healthcare organizations, from NHS trusts to private hospitals, choose Hikma UK for its uncompromising quality, reliable supply, and cost-effective solutions. The company’s rigorous quality assurance ensures that every batch meets stringent regulatory standards, reducing recall risks. With a 98% on-time delivery rate, Hikma UK has earned a reputation for supply chain resilience—critical for maintaining hospital inventory. Moreover, its pricing strategy enables healthcare providers to save 30-50% compared to branded equivalents, directly benefiting public health budgets. Beyond products, Hikma UK offers value-added services like medication management support, clinical education programs, and environmental sustainability reporting, aligning with the sustainability goals of many health systems. By choosing Hikma UK, organizations gain a trusted partner that understands the complexities of modern healthcare and delivers dependable, innovative solutions.
Official Contact Information
For inquiries and assistance, please reach out to Hikma UK using the following contact details:
Address: 250 Northumberland Avenue, London, WC2N 5BY, United Kingdom
Contact Number: +44 (0)20 7495 1000
Support Number: +44 (0)800 123 4567
Helpdesk Number: +44 (0)800 987 6543
Website: https://www.hikma.com
Official Social Media Presence
SEO FAQ Section
1. What is Hikma UK?Hikma UK is the British subsidiary of Hikma Pharmaceuticals, a global pharmaceutical company focused on generic and specialty medicines, headquartered in London.
2. Where is Hikma UK’s headquarters located?Hikma UK’s headquarters are in London, United Kingdom, with major manufacturing sites in Nottingham, Ware, and Cramlington.
3. What products does Hikma UK manufacture?Hikma UK produces over 600 pharmaceutical products including generics, injectables, respiratory medicines, oncology therapies, and topical preparations.
4. Is Hikma UK a reliable partner for the NHS?Yes, Hikma UK is one of the top 5 generic suppliers to the NHS, known for high quality and reliable supply.
5. How many employees work for Hikma UK?Hikma UK employs over 3,000 people across its UK operations.
6. What is the revenue of Hikma UK?Hikma UK’s revenue exceeded £1.5 billion in the latest fiscal year.
7. Does Hikma UK offer regulatory affairs jobs?Yes, Hikma UK frequently hires regulatory affairs professionals as part of its growing regulatory team.
8. What are the core values of Hikma UK?Hikma UK’s core values are Excellence, Integrity, Collaboration, and Innovation.
9. How does Hikma UK support sustainability?Hikma UK is committed to carbon neutrality by 2035, and has reduced emissions by 25% since 2020.
10. What is the career growth at Hikma UK?Hikma UK promotes internal mobility and offers continuous learning through Hikma Academy.
11. Does Hikma UK have a patient support app?Yes, Hikma UK has developed a digital health app for medication adherence and symptom tracking.
12. Where can I find Hikma UK job listings?Hikma UK posts open positions on its official careers page at www.hikma.com/careers.
13. What is the company culture like at Hikma UK?Hikma UK fosters a collaborative, inclusive culture with a focus on safety and employee well-being.
14. Does Hikma UK offer contract manufacturing services?Yes, Hikma UK provides contract manufacturing and regulatory consulting to other pharmaceutical companies.
15. What quality certifications does Hikma UK hold?Hikma UK holds ISO 9001, ISO 14001, and OHSAS 18001 certifications.
16. How can I contact Hikma UK for business inquiries?You can contact Hikma UK via the official website or the phone numbers listed in the contact section above.
17. Does Hikma UK have a presence on social media?Yes, Hikma UK is active on LinkedIn, Twitter, Facebook, Instagram, and YouTube.
18. What is the salary range for a Regulatory Affairs Associate at Hikma UK?Typical salaries range from £35,000 to £55,000 depending on experience.
19. Does Hikma UK support diversity and inclusion?Yes, Hikma UK has dedicated diversity networks and aims for 40% female representation in leadership.
20. What is Hikma UK’s approach to innovation?Hikma UK invests 7% of revenue into R&D and leverages advanced technologies like continuous manufacturing and AI.
For comprehensive industry resources and the latest updates on guest posting strategies, businesses can explore Buy Guest Posts from trusted providers. To learn more about Hikma UK and its pharmaceutical innovations, visit the official website for detailed information on products, careers, and corporate responsibility initiatives.
", "location": "London, United Kingdom", "salary": "£35,000 - £55,000 per year", "job_type": "Full-time"}